光医院实证医学竞赛

h
5
Critically Appraised Article (1)
結果 (若有計算NNT、RR、OR等，請一併列出)：
評論：
臨床最重要的結論(clinical bottom line)：
證據強度(level of evidence)：
h
6
Critically Appraised Article (2)
新光醫院 實證醫學競賽
組員：
1.
2.
3.
4.
5.
6.
h
http://ELC.skh.org.tw/
日期：96年8月4日
1
PICO
P I C O
h
2
Database Source
資料庫資源：
1. PubMed 2. OVID 3. 其他：
h
3
Search Terms & Strategy
搜尋關鍵字：
2b
Cohort study or poor RCT
2c
‘Outcomes’ research
3a
Systemic review of case-control studies
3b
Case-control study
[C]
4
Case series
[D]
5
Expert opinion, physiology, bench research
h
12
h
13
1C4G7JbMePhTkWnZr$u(x+A2E5H8 KcNfRiUlXp#s %v)y 0C3F6Ia LdOgSjVnYq!t*w- z1 D4G8Jb MeQhT kWoZr $u(x+ B2E5H9 KcNfRiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*w-A 1D4G8 JbNeQ hTlWo Zr%u(y +B2E6 H9Kc OfRjUmXp!s&v)z0C3 F7IaMdPgSkV nYq$t* x-A1D5 G8JbN eQiTlWo#r%u (y +B3E6H9L cOfRjUmYp!s&w)z0 C4F7Ja MdPhSkVnZq$ u*x-A2 D5G8 KbNeQiTlXo#r %v(y +B3E6I9 LcOgRjUmYp!t&w)z1C4F7J aMePhSkWnZ q$u*x +A2D5 H8KbN fQiUlX o#s%v (y 0B3F6I9LdO gRjVmYq!t&wz1C4G7JaMePhTkWnZr$u*x+ A2E5H8 KcNf QiUlXp #s%v)y 0B3F6I aLdOg SjVmYq!t*w-z1D4G7 JbMeQ hT kWo Zr$u(x +B2E5 H9KcN fRiUlX p#s&v)y 0C3F6IaLdPgSjVnYq!t*w- A1D4G 8JbMe QhTlW oZr%u( x+B2E 6H9Kc OfRiUmXp!s&v) z0C3F7IaM dPgSkVnYq$t*x-A1D 5G8Jb NeQhTlWo#r %u(y +B2E6H9 LcOfRjUmXp!s&w)z0C4F7I aMdP hSkVnZ q$t*x-A 2D5G8 KbNe QiTlXo #r%v(y +B3E6I 9LcOg RjUmYp!s&w)z1C4F7JaMdPhSkWn Zq$u* x-A2D5 H8Kb NfQiTlXo#s%v (y 0B3E6I9Ld OgRjVmYp!t&wz1C4G7JaMePhTkWnZr$u*x+ A2D5H 8KcNf QiUiUlXp#s%v )y 0B3F6I9Ld OgSjVmYq!t&w-z1D4 G7JbM ePhTkWoZr$ u(x+A2 E5H9K cNfRiUlXp#s&v)y 0C3F6IaL dPgSjVnYq!t*w-A1D 4G8Jb MeQhT kWoZr %u(x+ B2E5H 9KcOf RiUmXp#s&v) z0C3F7 IaLdPgSkVnY q$t*w- A1D5G 8JbNe QhTlW o#r%u(y +B2E 6H9Lc OfRjUmXp!s&w)z0C4F7IaM dPgSkVnZq$t* x-A1D 5G8Kb NeQiTlWo#r %v(y +B3E6H9 LcOgRjUmYp!s&w)z1C4F7J aMdPhSkWnZ q$u*xA2D5H8KbNfQiTlXo#r%v(y 0B3E6I9LcOgRjVmYp!t&w)z1 C4G7J aMePhSkWnZ r$u*x+ A2D5H 8KcNf QiUlX o#s%v)y 0B3F6 I9LdO gSjVmYq!t&w-z1C4G 7JbMePhT kW nZr$u( x+A2E 5H8Kc NfRiUlXp#s% v)y 0C3F6IaLd OgSjVnYq!t* w- z1D4 G8JbM eQhT kWoZr% u(x+B2E5H9 KcOfRiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*w-A 1D4G8J bNeQh TlWoZ r%u(y +B2E6 H9KcO fRjUmXp!s&v)z0C4F7IaMdPgSkVn Zq$t*x- A1D5 G8JbNe QiTlW o#r%u(y +B3E 6H9Lc OfRjUmYp!s&w)z0C4F7JaM dPhSkVnZq$u *xA2D5G8KbNfQiTlXo#r%v(y 0B3E6I9LcOgRjUmYp!t&w)z1 C4F7Ja MePhSkWnZq $u*x+ A2D5H 8KbNf QiUlXo #s%v(y 0B3F6 I9LdOg RjVmYq!t&w-z1C4G 7JbMePhT kW nZr$u( x+A2E 5H8Kc NfQiUlXp#s% v)y 0B3F6IaLd OgSjVmYq!q!t*w- z1 D4G7J bMeQh T kWoZ r$u(x+ B2E5H 9KcNf RiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*w- A1D4G 8JbNe QhTlW oZr%u( x+B2E 6H9Kc OfRiUmXp!s&v) z0C3F7IaM dPgSkVnYq$t*x-A1D 5G8Jb NeQiTlWo#r% u(y +B3E6H9 LcOfRjUmYp!s&w)z0 C4F7Ia MdPhSkVnZq $t*xA2D5G8KbNeQiTlXo#r%v(y +B3E6I9LcOgRjUmYp!t&w)z1C4F7J aMePhSkWnZ q$u*x+ A2D5 H8KbNf QiTlX o#s%v(y 0B3E6 I9LdO gRjVmYp!t&w-z1C4 G7JaMePhT kWnZr$u *x+A2 E5H8K cNfQiU lXp#s %v)y 0B3F6IaL dOgSjVmYq!t*w- z1D 4G7Jb MePhT kWoZr $u(x+A 2E5H9 KcNfRiUlXp# s&v)y 0C3F6IaLdPgSjVnYq!t*w-A1 D4G8J bMeQh TlWoZ r%u(x+ B2E6H 9KcOf RiUmXp#s&v) z0C3F7IaLdPgSkVn Yq$t*w- A1D5 G8JbNe QhTlW o#r%u (y +B2E6H9Lc OfRjUmXp!s&w)z0C4F7Ia MdPhSkVnZq$t*xA2D5G8KbNeQiTlWo#r%v(y +B3E6H9LcOg RjUmYp!s&w)z1C4F7JaMdPhSkWn Zq$u*x -A2D5 H8Kb NfQiTlXo#s%v (y 0B3E6I9Ld OgRjVmYp!t&w)z1C4 G7JaM ePhSkWnZr$u *x+A2 D5H8 KcNfQiUlXo#s %v)y 0B3F6I9 LdOgSjVmYq!t&w-z1 D4G7J bMePhT kWoZ r$u(x+ A2E5H 8KcNf RiUlXp #s%v)y 0C3F6 IaLdO gSjVnYq!t*w- z1D4G 8JbMe QhT kW oZr%u( x+B2E 5H9Kc OfRiUmXp#s&v) z0C3F7IaL dPgSkV nYq$t* w-A1 D4G8Jb NeQhT lWoZr %u(y +B2E6H9 KcOfRjUmXp!s&v)z0C4F7I aMdPgSkVnZ q$t*xA1D5G8KbNeQiTlWo#r%v(y +B3E6H9LcOf RjUmYp!s&w)z0C4F7 JaMdPhSkVn Zq$u*x- A2D5 G8KbN fQiTlX o#r%v(y 0B3E 6I9LcO gRjVmYp!t&w)z1C4 G7JaM ePhSkWnZq$u *x+A2 D5H8K bNfQiUlXo#s %v(y 0B3F6F6I 9LdOg RjVmYq!t&w-z1C4G 7JbMePhT kW nZr$u(x +A2E5 H8Kc NfRiUlXp#s% v)y 0C3F6IaLd OgSjVnYq!t*w - z1D4 G7JbM eQhT kWoZr$u (x+B2 E5H9K cNfRiUmXp#s&v)y 0C3F7Ia LdPgSjVnYq$t*w-A1 D4G8Jb NeQhT lWoZr %u(y +B2E6H 9KcOf RjUmXp!s&v)z0C3F7I aMdPgSkVnY q$t*xA1D5G8JbNeQiTlWo#r%u(y +B3E6H9LcOfRjUmYp!s&w)z0C4F7J aMdPhSkVnZ q$u*x- A2D5G 8KbNe QiTlXo #r%v(y +B3E6 I9LcO gRjUmYp!t&w)z1C4F7JaMePhSkW nZq$u* x+A2D 5H8Kb NfQiU lXo#s %v(y 0B3F6I9L dOgRjVmYp!t&w-z1 C4G7Ja MePhT kWnZr $u*x+ A2E5H8 KcNf QiUlXp #s%v)y 0B3F6I aLdOg SjVmYq!t*w-z1D4G7 JbMeQ hT kW oZr$u(x +B2E5 H9Kc NfRiUlXp#s&v)y 0C3F6IaLdPgSjVnYq!t*w- A1D4G 8JbMe QhTlW oZr%u (x+B2E 6H9Kc OfRiUmXp!s&v) z0C3F7IaM dPgSkVnYq$t*wA1D5G8JbNeQhTlWo#r%u(y +B2E6H9LcOf RjUmXp!s&w)z0C4F7 IaMdPhSkVnZ q$t*x- A2D5G 8KbNe QiTlXo #r%v(y +B3E6 H9Lc OgRjUmYp!s&w)z1C4 F7JaM dPhSkWnZq$u *x-A2 D5H8K bNfQiT lXo#s %v(y 0B3E6I9L dOgRjVmYp!t&w-z1 C4G7Ja MePhT kWnZr $u*x+ A2D5H 8KcNf QiUlXo #s%v)y 0B3F6 I9LdO gSjVmYq!t&w-z1D4 G7JbMeP hT kW oZr$u( x+A2E 5H9Kc NfRiUlXp#s&v)y 0C3F6IaLd OgSjVnYq!t* w- z1D4 G8JbM eQhT kWoZr% u(x+B2E5H9 KcOfRiUmXp#s&v)z0 C3F7Ia LdPgSkVnYq $t*wA1D5G8JbNeQhTlWo#r%u(y +B2E6H9KcOf RjUmXp!s&v)z0C4F7 IaMdPgSkVnZ q$q$t* x-A1D5 G8Kb NeQiTlWo#r% v(y +B3E6H9L cOgRjUmYp!s&w)z1 C4F7Ja MdPhSkWnZq $u*x- A2D5G 8KbNf QiTlXo #r%v(y 0B3E6I 9LcOg RjVmYp!t&w)z1C4G 7JaMePhSkWn Zr$u*x +A2D 5H8Kc NfQiUlXo#s% v)y 0B3F6I9Ld OgSjVmYq!t&w-z1C4G7Jb MePhTkWnZr$ u(x+A 2E5H8 KcNfRiUlXp#s %v)y 0C3F6Ia LdOgSjVnYq!t*w- z1 D4G8Jb MeQh T kWoZ r%u(x+ B2E5H 9KcNf RiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*wA1D4G8JbNeQhTlWoZr%u(y +B2E6H9KcOf RjUmXp!s&v)z0C4F7 IaMdPgSkVnZ q$t*x- A1D5G 8JbNe QiTlWo #r%u(y +B3E6 H9LcO fRjUmYp!s&w)z0C4 F7JaMdPhSkV nZq$u* x-A2D 5G8Kb NfQiTlXo#r% v(y 0B3E6I9Lc OgRjUmYp!t&w)z1C4F7Ja MePhSkWnZq$ u*x+A 2D5H8 KbNfQiUlXo# s%v(y 0B3F6I9 LdOgRjVmYq!t&w-z1C4G7 JbMeP hT kWn Zr$u*x +A2E5 H8KcN fQiUlXp#s%v )y 0B3F6IaLd OgSjVmYq!t*w- z1D4 G7JbM eQhT kWoZr$u (x+B2 E5H9K cNfRiUmXp#s&v)y 0C3F7Ia LdPgSjVnYq!t*wA1D4G8JbMeQhTlWoZr%u(x+B2E6H 9KcOf RiUmXp!s&v) z0C3F7 IaMdPgSkVn Yq$t*x- A1D5 G8JbNe QiTlW o#r%u(y +B2E 6H9Lc OfRjUmXp!s&w)z0C4 F7IaM dPhSkV nZq$t* x-A2D 5G8Kb NeQiTlXo#r% v(y +B3E6I9L cOgRjUmYp!t&w)z1 C4F7Ja MdPhSkWnZq$ u*x-A 2D5H8 KbNfQiTlXo#s %v(y 0B3E6I9 LdOgRjVmYp!t&w-z1C4G7 JaMeP hT kWn Zr$u*x +A2E5 H8KcN fQiUlXp#s%v )y 0B3F6I9Ld OgSjVmYq!t&w-z1D4 G7JbM ePhTkWoZr$u (x+A2 E5H9K cNfRiUlXp#s&v)y 0C3F3F6I aLdPgSjVnYq!t*wA1D4G8JbMeQhTlWoZr%u(x+B2E6H 9KcOf RiUmXp#s&v) z0C3F7IaLdPgSkVn Yq$t*w- A1D5 G8JbNe QhTlW o#r%u (y +B2E6H9Lc OfRjUmXp!s&w)z0C4F7Ia MdPhSkVnZq$t*x-A1 D5G8K bNeQiT lWo#r %v(y +B3E6H9 LcOgRjUmYp!s&w) z1C4F7 JaMdPhSkWn Zq$u*x- A2D5 H8KbN fQiTlX o#s%v(y 0B3E 6I9LcO gRjVmYp!t&w)z1C4 G7JaM eP hSkWnZr$u *x+A2 D5H8K cNfQiUlXo#s %v)y 0B3F6I9L dOgSjVmYq!t&w-z1 D4G7J bMePhT kWoZ r$u(x+ A2E5H 8KcNf RiUlXp #s%v)y 0C3F6I aLdOg SjVnYq!t*wz1D4G8JbMeQhTkWoZ r%u(x+ B2E5H 9KcOf RiUmXp#s&v) z0C3F7IaLdPgSjVnYq$t*w- A1D4G 8JbNe QhTlW oZr%u(y +B2E 6H9Kc OfRjUmXp!s&v)z0C4F7IaM dPgSkVnZq$t* x-A1D 5G8Kb NeQiTlWo#r %v(y +B3E6H9 LcOfRjUmYp!s&w)z0C4F7J aMdPhSkVnZq $u*x- A2D5G 8KbNf QiTlXo #r%v(y 0B3E6I 9LcOg RjVmYp!t&w)z1C4G 7JaMeP hSkW nZq$u* x+A2D 5H8Kb NfQiUlXo#s% v(y 0B3F6I9Ld OgRjVmYq!t&w-z1C4G7Jb MePhT kWnZr $u(x+A 2E5H8 KcNfRiUlXp# s%v)y 0B3F6Ia LdOgSjVmYq!t*wz1D4G7JbMeQhTkWoZ r$u(x+ B2E5H 9KcNf RiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*w- A1D4G 8JbNeQ hTlWo Zr%u( x+B2E6 H9Kc OfRiUmXp!s&v) z0C3 F7IaMdPdPgSkVnYq$ t*x-A1 D5G8J bNeQiTlWo#r %u(y +B3E6H 9LcOfRjUmYp!s&w) z0C4F7 JaMdPhSkVnZ q$t*x- A2D5G 8KbNe QiTlXo #r%v(y +B3E6 I9LcO gRjUmYp!t&w)z1C4F7JaMePhSkW nZq$u* x+A2D 5H8Kb NfQiU lXo#s %v(y 0B3F6I9L dOgRjVmYp!t&w-z1 C4G7Ja MePhT kWnZr $u*x+ A2E5H8 KcNf QiUlXp #s%v)y 0B3F6I aLdOg SjVmYq!t*wz1D4G7JbMeQhTkWoZ r$u(x+ A2E5H 9KcNf RiUlXp #s&v)y 0C3F6IaLdPgSjVnYq!t*w-A 1D4G8J bMeQ hTlWo Zr%u(x +B2E6 H9KcO fRiUmXp!s&v) z0C3F7IaMdPgSkVn Yq$t* w-A1D5 G8JbN eQhTlWo#r% u(y +B2E6H9L cOfRjUmXp!s&w)z0 C4F7Ia MdPhSkVnZq$ t*x-A2 D5G8 KbNeQiTlXo#r %v(y +B3E6H 9LcOg RjUmYp!s&w)z1C4F7JaMdP hSkWn Zq$u*x -A2D5 H8Kb NfQiTlXo#s%v (y 0B3E6I9Ld OgRjVmYp!t&w-z1C4 G7JaM ePhSkWnZr$u *x+A2 D5H8 KcNfQiUlXo#s %v)y 0B3F6I9 LdOgSjVmYq!t&wz1D4G7JbMePhTkWoZr$u(x+ A2E5H9 KcNfRiUlXp# s&v)y 0C3F6IaLdOgSjVnYq! t*w- z1 D4G8J bMeQh T kWo Zr%u(x +B2E5 H9KcO fRiUmXp#s&v) z0C3F7IaLdPgSkVn Yq$t*w -A1D5 G8JbN eQhTlWoZr% u(y +B2E6H9K cOfRjUmXp!s&v)z0 C4F7Ia MdPgSkVnZq$ t*x-A1 D5G8K bNeQiTlWo#r %v(y +B3E6H 9LcOg RjUmYp!s&w)z1C4F7F7JaM dPhSkWnZq$ u*x-A2 D5G8K bNfQiTlXo#r %v(y 0B3E6I9 LcOgRjVmYp!t&w)z1 C4G7J aMePhSkWnZ r$u*x+ A2D5H 8KcNf QiUlX o#s%v)y 0B3F6 I9LdO gRjVmYq!t&wz1C4G7JbMePhTkWnZr$u(x+A 2E5H8 KcNfRiUlXp# s%v)y 0C3F6Ia LdOgSjVnYq! t*w- z1 D4G8J bMeQh T kWo Zr%u(x +B2E5 H9KcN fRiUmXp#s&v)y 0C3F7IaLdPgSjVnYq$t*w -A1D4 G8JbNe QhTlWoZr%u (y +B2E6H9K cOfRjUmXp!s&v)z0C4F7Ia MdPgSkVnYq$t*x-A1 D5G8Jb NeQiT lWo#r %u(y +B3E6H9 LcOfRjUmYp!s&w)z0C4F7J aMdP hSkVnZ q$u*x- A2D5G 8KbNf QiTlXo #r%v(y +B3E6 I9LcO gRjUmYp!t&w)z1C4F7JaMePhSkW nZq$u* x+A2D 5H8Kb NfQiUlXo#s% v(y 0B3F6I9Ld OgRjVmYq!t&wz1C4G7JbMePhTkWnZr$u*x+ A2E5H8 KcNf QiUlXp #s%v)y 0B3F6I aLdOg SjVmYq!t*w-z1D4G7 JbMeQ hT kWo Zr$u(x +B2E5 H9KcN fRiUmXp#s&v)y 0C3F6IaLdPgSjVnYq!t*w -A1D4 G8JbM eQ
題目及出處：
研究設計：
RAMbo of RCT：
Randomization: Accountability: Measurable outcome:
Blinding: Objectivity:
h源自文库
7
Critically Appraised Article (2)
結果 (若有計算NNT、RR、OR等，請一併列出)：
搜尋歷程(運用limits)：
h
4
Critically Appraised Article (1)
題目及出處：
研究設計：
RAMbo of RCT：
Randomization: Accountability: Measurable outcome:
Blinding: Objectivity:
評論：
臨床最重要的結論(clinical bottom line)：
證據強度(level of evidence)：
h
8
Clinical Application
請嘗試以去學術化術語的方式回答病人的問題
問題：
回答：
證據是否能應用到臨床個案？
應用： Grade of recommendation：
有何困境？經濟成本效益？
困境： 成本效益：
h
9
Your Conclusions
請寫下你們組員相互討論的結論
h
10
參考資料：證據的強度
h
11
參考資料：臨床建議
Grade of Recommendation
[A]
[B]
Level of Evidence
1a 1b 1c 2a
Therapy
Systemic review of RCTs Single RCT ‘All-or-none’ Systemic review of cohort studies